Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Heron Therapeutics (HRTX) has issued an update.
Ira Duarte has been appointed as the new principal accounting officer of Heron Therapeutics, Inc., set to take over from Lisa Peraza on March 29, 2024. Duarte’s background information is available from a previous SEC filing, with no arrangements or family ties influencing her selection. There are no financial conflicts of interest, and her compensation will remain unchanged in her new role.
For a thorough assessment of HRTX stock, go to TipRanks’ Stock Analysis page.